- Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.
- Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.
- Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.
- Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.
Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.
16 reports, 8 independent
Updated Sep 21
Gone quiet
Reached 5 outlets in its first 24 hours
- Reports
- 16
- Developments
- 3
- Repetition
- 88%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.J&J divests its over-the-counter business unit.1 source
- Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sub-event
J&J spun off its Consumer Health business into Kenvue.1 source
Keep exploring
The entities involved
-
Kenvue
American consumer health company
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Related events
- Johnson & Johnson is reportedly considering a sale of its orthopedics business unit within DePuy Synthes.
- Johnson & Johnson highlighted growth opportunities within the MedTech sector.
- Johnson & Johnson and Recordati Industria Chimica E Farmaceutica are noted as large-cap healthcare companies.
- JNJ secured marketing authorization from the U.S. FDA, and its Ottava platform challenges ISRG's market dominance.
- Johnson & Johnson started its roots in New Jersey.
Coverage
Newest first; wire copies grouped- fool.com
- fool.comThis "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It | The Motley Fool
- yahoo.comThis "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It
- insidermonkey.com
- fool.com
- ZacksJ&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy? Johnson & Johnson’s JNJ stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since mid-June. It achiev
- ReutersKenvue attracts share purchase by activist investor Sachem Head By Svea Herbst-Bayliss NEW YORK (Reuters) -Band-Aid and Tylenol maker Kenvue attracted the attention of another activist investor in th
- ReutersBand-Aid maker Kenvue cuts annual sales forecast amid strategic review By Sneha S K (Reuters) -Kenvue cut its annual sales forecast on Thursday, as the consumer health company undergoes a strategic r
- Insider MonkeyIs Kenvue (KVUE) a Halal Dividend Stock Worth Adding to Your Portfolio? Kenvue Inc. (NYSE:KVUE) is included among the 11 Best Halal Dividend Stocks to Buy Now. A pharmacist at a local store, stocking
- ZacksJNJ Begins Drug Sector Q2 Earnings With a Beat & Guidance Raise Johnson & Johnson’s JNJ second-quarter 2025 earnings came in at $2.77 per share, which beat the Zacks Consensus Estimate of $2.66. Earn
- Motley FoolWant to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock. Kenvue is spending big to drum up demand for its diversified product portfolio. The company's
- WWDKirk Perry Appointed Interim CEO of Kenvue Amid Strategic Review Thibaut Mongon has departed as chief executive officer of Kenvue and stepped down from the board. Kirk Perry has been named interim CE
- Unknown outlet
- Unknown outlet
- Unknown outlet
- Unknown outlet